Abstract Details
|
Mark Keroles, MD
PRESENTER |
Dr. Keroles has received intellectual property interests from a discovery or technology relating to health care. |
| Brian Stocksdale, MD (Stanford Health Care) | Dr. Stocksdale has nothing to disclose. |
| Jessica P. Ng, MD | Dr. Ng has nothing to disclose. |
| Sahar Ahadi, MD | Dr. Ahadi has nothing to disclose. |
| Jeffrey E. Dunn, MD, FAAN (Stanford University Medical Center) | Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Dunn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec Diagnostics. Dr. Dunn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna Therapeutics. Dr. Dunn has received intellectual property interests from a discovery or technology relating to health care. |